biostudies-literatureUnknown31(2)Drillaud NSobi in accordance with Good Publication Practice<h4>Background</h4>Haemophilia management aims to prevent bleeding and preserve joint function. Changes in patients' joint health may influence physicians' decisions to adjust treatment. The Haemophilia Joint Health Score (HJHS) and Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score assess joint health but are not routinely used.<h4>Aim</h4>To evaluate whether systematic joint examination with HJHS and/or HEAD-US had an impact on treatment management decisions in France, using final data from the A-MOVE study.<h4>Methods</h4>A-MOVE (NCT04133883) was a 12-month prospective, multicentre study, which enrolled persons with haemophilia A (all severities, aged 6-40 years) treated prophylactically or on demand with standard/extended half-life FVIII replacement. At baseline, 6Haemophilia : the official journal of the World Federation of Hemophilia239-246https://www.ebi.ac.uk/biostudies/studies/S-EPMC11957421biostudies-literatureImpact of Systematic Joint Examination (Ultrasound, Functional and Physical) on Treatment Management Decisions in Patients With Haemophilia A in France: Final Data From the Prospective, Observational A-MOVE Study.PMC11957421Marie Castet SFrotscher BDesprez DBeurrier PZidi MOudot CDrillaud NFouassier MBarbay VA‐MOVE study groupd'Oiron RBiron-Andreani CJailler RFusser MRepesse YBlanc LMahdout OChambost HLebreton AAlenas MCastet SMJousse-Joulin SFrenzel LGenre-Volot FColinart MPan-Petesch BGandossi CValentin JBfalseImpact of Systematic Joint Examination (Ultrasound, Functional and Physical) on Treatment Management Decisions in Patients With Haemophilia A in France: Final Data From the Prospective, Observational A-MOVE Study.<h4>Background</h4>Haemophilia management aims to prevent bleeding and preserve joint function. Changes in patients' joint health may influence physicians' decisions to adjust treatment. The Haemophilia Joint Health Score (HJHS) and Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score assess joint health but are not routinely used.<h4>Aim</h4>To evaluate whether systematic joint examination with HJHS and/or HEAD-US had an impact on treatment management decisions in France, using final data from the A-MOVE study.<h4>Methods</h4>A-MOVE (NCT04133883) was a 12-month prospective, multicentre study, which enrolled persons with haemophilia A (all severities, aged 6-40 years) treated prophylactically or on demand with standard/extended half-life FVIII replacement. At baseline, 62025-01-01T00:00:00Z2025 Mar2026-06-01T22:59:34.716Z2025-07-13T03:04:29.153ZS-EPMC119574213999498610.1111/hae.70012